AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Photocure ASA

Report Publication Announcement • Nov 29, 2019

3714_rns_2019-11-29_8e5fccee-be28-42da-8ba6-0879ead1f15d.pdf

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Photocure to present at Nordic-American Life Science Conference in New York

Oslo, Norway, November 29, 2019 - PhotocureASA (OSE: PHO) will be presenting at the Nordic-American Life Science Conference in New York on December 5.

The presentation is scheduled at 8:30am EDTand will be held by Dan Schneider, President and CEOof PhotocureASA. The presentation will be posted on www.photocure.com when held on December 5.

Company contact: Erik Dahl Chief Financial Officer Tel: +47 450 55 000 Email: [email protected]

About PhotocureASA

Photocure, The Bladder Cancer Company, delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com